HOME >> MEDICINE >> NEWS
International trial of two microbicides begins

A large, multisite trial designed to examine the safety and preliminary effectiveness of two candidate topical microbicides to prevent HIV infection has opened to volunteer enrollment. The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, represents a partnership among various research institutions in Africa and the United States.

Although no licensed microbicides are available to the public currently, scientists hope these agents--designed to be applied to the surface of the vagina to prevent sexually transmitted infections (STIs)--will one day be a key tool in the fight against HIV/AIDS.

Women make up nearly half of all people living with HIV worldwide. "The majority of new cases of HIV infection in women result from heterosexual intercourse, but women may not always be able to insist that their male partners use measures to prevent HIV transmission," notes NIAID Director Anthony S. Fauci, M.D. "If effective, microbicides would be a valuable woman-controlled means of slowing the pace of the HIV/AIDS epidemic," Dr. Fauci adds.

The first volunteers were enrolled this week at sites in Durban, South Africa, and at the University of Pennsylvania in Philadelphia. Enrollment will begin shortly at sites in four additional African countries--Malawi, Tanzania, Zimbabwe and Zambia. Approximately 3,220 women will be enrolled in the trial, which is expected to last approximately 30 months.

"This is the first microbicide safety and effectiveness trial of this magnitude to be conducted by NIAID," says Roberta J. Black, Ph.D., Topical Microbicide Team Leader in NIAID's Division of AIDS. "It is a critical trial evaluating two topical microbicides with differing mechanisms of action," she adds.

The microbicides to be tested are PRO 2000 and BufferGel. Produced by Indevus Pharmaceuticals, Lexington, MA, PRO 2000 has shown activity against HIV and other STIs in bot
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
11-Feb-2005


Page: 1 2

Related medicine news :

1. International breast cancer prevention study launches in the United States and Canada
2. National Academies advisory: May 2 Symposium on International Science Policy
3. Awards & fellowships at the International & American Association for Dental Research General Session
4. Lectures, keynoters, symposia highlight International Dental Research meeting
5. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
6. International gathering of experts to share retinoblastoma breakthroughs
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... Va. (PRWEB) , ... June 26, 2020 , ... ... a call for participation in the revision and redesignation of the ANSI/APSP/ICC-7 2013 ... Hot Tubs, and Catch Basins. PHTA is seeking member participation on the PHTA-7 ...
(Date:6/28/2020)... , ... June 27, 2020 , ... The secret of ... of hundreds of rolls of toilet paper. Yet, it was the first product to ... sensible in theory. The more you have stockpiled, the less need to venture out, ...
(Date:6/24/2020)... ... 24, 2020 , ... Evolved Naturals, a new brand of CBD health and ... The newly launched website showcases a variety of health and beauty CBD ... line of skincare & topical products . , Doug Gee, the CEO ...
(Date:6/24/2020)... ... ... Skyroam , the developer of patented virtual SIM (vSIM) technology for ... of enterprise software for testing laboratories, in which its Skyroam Solis Lite 4G LTE ... Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global effort that ...
(Date:6/23/2020)... (PRWEB) , ... June 23, ... ... , an expert in increasing revenue for hospitals and specialty physician practices ... , a high-growth vertical payments company. , The partnership will enable Sunbelt ...
Breaking Medicine News(10 mins):
(Date:6/25/2020)... ... June 25, 2020 , ... NeoTract, a wholly ... field of urology, today announced that Tarek Pacha, D.O., Memorial Heathcare in Owosso, ... that Dr. Pacha has achieved a high level of training and experience with ...
(Date:6/25/2020)... LEXINGTON, Mass. (PRWEB) , ... June 25, 2020 ... ... its 27th annual International Research Congress (IRC) , which is being conducted ... widely seen as the premier global platform for the discussion and dissemination of ...
(Date:6/25/2020)... ... June 25, 2020 , ... Drs. Gregory Toback and ... within the Periodontics category. As specialists, this team of periodontists offers ... RI. Laser gum disease therapy, minimally invasive gum recession treatment, and life-changing dental ...
Breaking Medicine Technology:
Cached News: